Many insurers are restricting access to new drugs that are easier to take and that promise higher cure rates because the price tags can run $95,000 or more.
The new product brings several advances, but it also has a steep price tag, reported at $1,125 per tablet. Its maker reported billions in sales of a related drug approved last year.
The first in a new class of drugs that can cure the viral infection that is the leading cause of liver failure and liver cancer is poised for a marketing green light from the Food and Drug Administration. More than 3 million Americans have hepatitis C, but most don't know it.